Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 4768408, 9 pages
https://doi.org/10.1155/2017/4768408
Research Article

Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren’s Syndrome

Yuzhou Gan,1,2,3 Xiaozhen Zhao,1,2,3 Jing He,1,2,3 Xu Liu,1,2,3 Yun Li,1,2,3 Xiaolin Sun,1,2,3 and Zhanguo Li1,2,3

1Department of Rheumatology and Immunology, Peking University People’s Hospital and Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China
2Center of Clinical Immunology, Peking University, Beijing 100044, China
3Peking-Tsinghua Center for Life Sciences, Beijing, China

Correspondence should be addressed to Xiaolin Sun; moc.621@lxs_niloaixnus and Zhanguo Li; nc.ude.umjb@99il

Received 15 August 2016; Revised 4 November 2016; Accepted 9 November 2016; Published 22 January 2017

Academic Editor: Jacek Tabarkiewicz

Copyright © 2017 Yuzhou Gan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Brito-Zerón and M. Ramos-Casals, “Advances in the understanding and treatment of systemic complications in Sjögren's syndrome,” Current Opinion in Rheumatology, vol. 26, no. 5, pp. 520–527, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Alunno, F. Carubbi, O. Bistoni et al., “T regulatory and T helper 17 cells in primary Sjögren's syndrome: facts and perspectives,” Mediators of Inflammation, vol. 2015, Article ID 243723, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. G. E. Katsifis, S. Rekka, N. M. Moutsopoulos, S. Pillemer, and S. M. Wahl, “Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis,” The American Journal of Pathology, vol. 175, no. 3, pp. 1167–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. R. Reksten, M. V. Jonsson, E. A. Szyszko, J. G. Brun, R. Jonsson, and K. A. Brokstad, “Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome,” Rheumatology, vol. 48, no. 9, pp. 1102–1106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. H. Kang, M. K. Kim, H. J. Lee, H. I. Lee, W. R. Wee, and J. H. Lee, “Interleukin-17 in various ocular surface inflammatory diseases,” Journal of Korean Medical Science, vol. 26, no. 7, pp. 938–944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Y. Lee, S. J. Han, S. M. Nam et al., “Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients,” American Journal of Ophthalmology, vol. 156, no. 2, pp. 247–253.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Fei, W. Zhang, D. Lin et al., “Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome,” Clinical Rheumatology, vol. 33, no. 4, pp. 523–529, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Tan, S. Sun, Y. Liu et al., “Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome,” Eye, vol. 28, no. 5, pp. 608–613, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Alunno, O. Bistoni, S. Caterbi, E. Bartoloni, G. Cafaro, and R. Gerli, “Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling,” Clinical and Experimental Rheumatology, vol. 33, no. 1, p. 129, 2015. View at Google Scholar · View at Scopus
  10. X. Lin, K. Rui, J. Deng et al., “Th17 cells play a critical role in the development of experimental Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 74, no. 6, pp. 1302–1310, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ohyama, M. Moriyama, J.-N. Hayashida et al., “Saliva as a potential tool for diagnosis of dry mouth including Sjögren's syndrome,” Oral Diseases, vol. 21, no. 2, pp. 224–231, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Gu, L. Wu, and X. Li, “IL-17 family: cytokines, receptors and signaling,” Cytokine, vol. 64, no. 2, pp. 477–485, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. W. B. van den Berg and I. B. McInnes, “Th17 cells and IL-17 a—focus on immunopathogenesis and immunotherapeutics,” Seminars in Arthritis and Rheumatism, vol. 43, no. 2, pp. 158–170, 2013. View at Google Scholar
  14. S. G. Hymowitz, E. H. Filvaroff, J. P. Yin et al., “IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding,” The EMBO Journal, vol. 20, no. 19, pp. 5332–5341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Kolls and A. Lindén, “Interleukin-17 family members and inflammation,” Immunity, vol. 21, no. 4, pp. 467–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Toy, D. Kugler, M. Wolfson et al., “Cutting edge: interleukin 17 signals through a heteromeric receptor complex,” The Journal of Immunology, vol. 177, no. 1, pp. 36–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kawaguchi, M. Adachi, N. Oda, F. Kokubu, and S.-K. Huang, “IL-17 cytokine family,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 6, pp. 1265–1273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. G. Shabgah, E. Fattahi, and F. Z. Shahneh, “Interleukin-17 in human inflammatory diseases,” Postępy Dermatologii i Alergologii, vol. 31, no. 4, pp. 256–261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Gomez-Rodriguez, N. Sahu, R. Handon et al., “Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase,” Immunity, vol. 31, no. 4, pp. 587–597, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Starnes, M. J. Robertson, G. Sledge et al., “Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production,” The Journal of Immunology, vol. 167, no. 8, pp. 4137–4140, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Watanabe, M. Kawaguchi, S. Fujishima et al., “Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis,” The Journal of Investigative Dermatology, vol. 129, no. 3, pp. 650–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Fujishima, H. Watanabe, M. Kawaguchi et al., “Involvement of IL-17F via the induction of IL-6 in psoriasis,” Archives of Dermatological Research, vol. 302, no. 7, pp. 499–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. X. O. Yang, S. H. Chang, H. Park et al., “Regulation of inflammatory responses by IL-17F,” The Journal of Experimental Medicine, vol. 205, no. 5, pp. 1063–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Seror, P. Ravaud, S. J. Bowman et al., “EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 1103–1109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ramos-Casals, P. Brito-Zerón, R. Seror et al., “Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements,” Rheumatology, vol. 54, no. 12, pp. 2230–2238, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Alunno, F. Carubbi, E. Bartoloni et al., “Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting?” Autoimmunity Reviews, vol. 13, no. 12, pp. 1167–1173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Ciccia, G. Guggino, A. Rizzo et al., “Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome,” Rheumatology, vol. 53, no. 7, Article ID keu004, pp. 1313–1320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Ishigame, S. Kakuta, T. Nagai et al., “Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses,” Immunity, vol. 30, no. 1, pp. 108–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. F. Wright, F. Bennett, B. Li et al., “The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex,” The Journal of Immunology, vol. 181, no. 4, pp. 2799–2805, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. E. Kuestner, D. W. Taft, A. Haran et al., “Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F,” The Journal of Immunology, vol. 179, no. 8, pp. 5462–5473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Komiyama, S. Nakae, T. Matsuki et al., “IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis,” The Journal of Immunology, vol. 177, no. 1, pp. 566–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Babaloo, M. R. Aliparasti, F. Babaiea, S. Almasi, B. Baradaran, and M. Farhoudi, “The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels,” Immunology Letters, vol. 164, no. 2, pp. 76–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Kawaguchi, L. F. Onuchic, X.-D. Li et al., “Identification of a novel cytokine, ML-1, and its expression in subjects with asthma,” The Journal of Immunology, vol. 167, no. 8, pp. 4430–4435, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. D. A. Giles, M. E. Moreno-Fernandez, T. E. Stankiewicz et al., “Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis,” PLoS ONE, vol. 11, no. 2, Article ID e0149783, 2016. View at Publisher · View at Google Scholar